BIO vs SGN · rev $651.0M vs rev $615.6K
BIO (BIO) versus Signing Day Sports, Inc. (SGN) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Signing Day Sports, Inc. (SGN) is a software - application company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported SGN revenue for 2024-12-31 was $615.6K. Net income was -$8.7M. Revenue was up 100.1% from 2023-12-31 to 2024-12-31. SGN currently screens at market cap $7.4M.
BIO currently screens at market cap $0. SGN currently screens at market cap $7.4M.
Not investment advice. Open the BIO and SGN stock pages for the full models.
Not investment advice.